SCHEMBL1461799

SCHEMBL1461799

CCOC(=O)c1cn(C2CC2)c2c(/C=C\CC3CN(C(=O)OC(C)(C)C)CCN3)c(F)c(F)cc2c1=O

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.44
KCNH2 Q12809 5/20 0.39
KDM4E B2RXH2 4/20 0.39
ALDH1A1 P00352 4/20 0.39
HPGD P15428 4/20 0.39
HSD17B10 Q99714 4/20 0.39
POLB P06746 1/20 0.39
PRKD3 O94806 1/20 0.39
ALOX15 P16050 1/20 0.39
OPRM1 P35372 1/20 0.39
CLK2 P49760 1/20 0.39
CLK4 Q9HAZ1 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
STAT3 P40763 1/20 0.36
BTK Q06187 1/20 0.35
TOP2A P11388 1/20 0.34
TOP2B Q02880 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL178577 0.85 ADRB2 (0.50) ADRB2KCNH2KDM4EALDH1A1HPGD
SCHEMBL142928 0.85 ADRB2 (0.50) ADRB2KCNH2KDM4EALDH1A1HPGD
SCHEMBL1462012 0.84 ADRB2 (0.44) ADRB2KCNH2KDM4EALDH1A1HPGD
SCHEMBL146707 0.83 ADRB2 (0.46) ADRB2KCNH2KDM4EALDH1A1HPGD
SCHEMBL145085 0.83 ADRB2 (0.46) ADRB2KCNH2KDM4EALDH1A1HPGD
SCHEMBL13625783 0.83 ADRB2 (0.46) ADRB2KCNH2KDM4EALDH1A1HPGD
SCHEMBL141426 0.82 ADRB2 (0.45) ADRB2KCNH2KDM4EALDH1A1HPGD
SCHEMBL116323 0.82 ADRB2 (0.45) ADRB2KCNH2KDM4EALDH1A1HPGD
SCHEMBL149073 0.82 ADRB2 (0.45) ADRB2KCNH2KDM4EALDH1A1HPGD
SCHEMBL178603 0.81 ADRB2 (0.49) ADRB2KCNH2KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011031740-A1 ANTIBACTERIAL FLUOROQUINOLONE ANALOGS ACHAOGEN, INC. (US) 2011-03-17 WO disclosed